Publications by authors named "Algeri Mattia"

Claim this Profile
T
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, Mattia Algeri, Alessandra Algarotti

Am J Hematol· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in health-related quality of life in patients with transfusion-dependent β-thalassemia after exagamglogene autotemcel.
Josu de la Fuente, Haydar Frangoul, Peter Lang, Donna Wall, Roland Meisel, Mattia Algeri

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosis.
Isabella Guzzo, Marco Becilli, Andrea Cappoli, Pietro Merli, Raffaella Labbadia, Mattia Algeri

Pediatr Nephrol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.
Franco Locatelli, Daria Pagliara, Maria A De Ioris, Marco Becilli, Giada Del Baldo, Mattia Algeri

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial.
Franco Locatelli, Daria Pagliara, Maria A De Ioris, Marco Becilli, Giada Del Baldo, Mattia Algeri

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care fresh CAR T cells for pediatric or young adult BCP-ALL that is relapsed/refractory or in very-high-risk first relapse.
Francesca Del Bufalo, Marco Becilli, Chiara Rosignoli, Pietro Merli, Mattia Algeri

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of children with haematological malignancies given second haploidentical haematopoietic stem cell transplantation with either TCRαβ/CD19 depletion or post-transplant cyclophosphamide.
Riccardo Masetti, Davide Leardini, Francesca Gottardi, Francesco Baccelli, Giorgio Antonio Maria Ottaviano, Mattia Algeri

Br J Haematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ENERGIZE trial: Is mitapivat ready to take center stage in NTDT management?
Mattia Algeri, Franco Locatelli

Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impairment of Innate Immunity and Depletion of Vaccine-Induced Memory B and T Cells in the Absence of the Spleen.
Veronica Bordoni, Bianca Laura Cinicola, Eva Piano Mortari, Concetta Castilletti, Federica Guarracino, Mattia Algeri

Am J Hematol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients: a multicenter study by ESID and EBMT IEWP.
Julia Fekadu-Siebald, Emilia Salzmann-Manrique, Jan Robert Heusel, Andre Willasch, Fabian Hauck, Mattia Algeri

Blood Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation.
Mattia Algeri, Michele Massa, Daria Pagliara, Valentina Bertaina, Federica Galaverna

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma.
Concetta Quintarelli, Francesca Del Bufalo, Maria Antonietta De Ioris, Marika Guercio, Mattia Algeri

Nat Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature.
Marita Bosticardo, Kerry Dobbs, Ottavia M Delmonte, Andrew J Martins, Francesca Pala, Mattia Algeri

Sci Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes.
Federica Galaverna, Sara Flamini, Carmen Dolores De Luca, Ilaria Pili, Emilia Boccieri, Mattia Algeri

Haematologica· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous CD19-Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis.
Rebecca Nicolai, Pietro Merli, Patricia Moran Alvarez, Claudia Bracaglia, Francesca Del Bufalo, Mattia Algeri

Arthritis Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity.
Su Han Lum, Michael H Albert, Patrick Gilbert, Tiarlan Sirait, Mattia Algeri

Blood· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study.
Annalisa Ruggeri, Nicole Santoro, Jacques-Emmanuel Galimard, Krzysztof Kalwak, Mattia Algeri

Haematologica· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties.
Stefano Giardino, Dirk-Jan Eikema, Brian Piepenbroek, Mattia Algeri, Mouhab Ayas

Am J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous gene therapy for hemoglobinopathies: From bench to patient's bedside.
Franco Locatelli, Marina Cavazzana, Haydar Frangoul, Josu de la Fuente, Mattia Algeri

Mol Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia.
Franco Locatelli, Peter Lang, Donna Wall, Roland Meisel, Selim Corbacioglu, Mattia Algeri

N Engl J Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCRαβ/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.
Pietro Merli, Mattia Algeri, Federica Galaverna, Valentina Bertaina, Barbarella Lucarelli

Blood· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome editing for sickle cell disease: still time to correct?
Giulia Ceglie, Marco Lecis, Gabriele Canciani, Mattia Algeri, Giacomo Frati

Front Pediatr· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease.
Mattia Algeri, Marco Becilli, Franco Locatelli

Expert Rev Clin Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis